Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD 1
Most Correlated Studies
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
- L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
- CD8+ CD3+ T cells from peripheral blood - PD-1-high, PD-1-low and naive
Most Relevant Literature
- PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism.
- Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (…
- New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.
- PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.
- PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.
Most Relevant Clinical Trials
- Duration of Anti-PD-1 Therapy in Metastatic Melanoma
- Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyng…
- SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Contro on PD-1/PDL-1 Tx
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
